Sarcopenia. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Sarcopenia - Группа авторов страница 20

Sarcopenia - Группа авторов

Скачать книгу

physical activity and increased representation of all mitochondrial proteins, both structural and functional [33]. A reduced physical activity, however, does not exhaustively explain the decline of mitochondrial function, since skeletal muscle oxidative capacity declines even after the effect of age is estimated after adjusting for physical activity [23, 26]. Although observational studies assessing changes of mitochondrial function with aging in individuals who maintain a high level of physical activity are lacking, randomized clinical trials have shown that regular physical activity and resistance exercise prevent age‐related sarcopenia [34–36]. The beneficial effect of physical activity on mitochondrial function is mostly mediated by mitochondrial biogenesis, driven by the upregulation of the peroxisome proliferator‐activated receptor γ coactivator‐1 α (PGC‐1α), [37, 38]. PGC‐1α modulates the biological activity of several transcription factors including the nuclear respiratory factors (NRF1 and NRF2) and mitochondrial transcription factors (TFAM and TF2B) [39], and its concentration in skeletal muscle has been associated with the degree of oxidative capacity and shown to decline with aging [29]. PGC‐1α also inhibits the Forkhead box O3a (FoxO3a) and nuclear factor κB (NF‐κB), both of which enhance muscle catabolism [40, 41]. In mice, the overexpression of PGC‐1α levels in skeletal muscle prevents age‐dependent sarcopenia [42]. Thus, increasing mitochondrial biogenesis or enhanced quality control processes by exercise or exercise mimetics is considered one of the possible strategies for sarcopenia prevention.

      Oxidative stress

      An important emergent target for ROS‐induced mitochondrial damage are cardiolipins. Cardiolipins are glycerophospholipids specific to the mitochondria with a unique dimeric structure of two phosphatidic acid moieties connected to a glycerol backbone. Although the variety of phosphatidic acids found in cardiolipin is extremely large, cardiolipin containing 18‐carbon fatty alkyl chains with two unsaturated bonds (18:2), the most frequent form, has probably the highest affinity to the inner membrane proteins of mammalian mitochondria, and is important to the structural integrity of the inner mitochondrial membrane and the preservation of the proper shape of the mitochondrial cristae. This is consistent with findings that show how low circulating levels of lysophosphatidylcholine 18:2 are strongly associated with the risk of losing mobility [45–47]. In eukaryotes, cardiolipins are only synthesized in the mitochondrion, where they remain throughout the mitochondrion lifespan. Functionally, cardiolipin binds to the complexes of the ETC to stabilize their reciprocal positioning and regulate their activation. In particular, cardiolipins interact with NADH‐dependent Coenzyme Q oxidoreductase (complex I), succinate dehydrogenase (complex II), ubiquinol cytochrome oxidoreductase (complex III), cytochrome c oxidase (complex IV), and complex V [48]. Cardiolipins are also responsible for anchoring to the mitochondrial membranes two important enzymes: the creatine kinase, which produces PCr from Cr, and the nucleoside diphosphate kinase, which catalyzes the exchange of terminal phosphate between different nucleoside diphosphates (NDPs) and triphosphates (NTPs), such as ATP, in a reversible manner. Cardiolipins participate in the induction of apoptosis by interacting with cytochrome c [48], and are essential for mitochondrial fission and fusion [49]. Excessive, unopposed oxidative stress may determine peroxidation of the cardiolipin, whose structure and proximity to the ETC makes it particularly vulnerable to ROS, leading to structural and functional changes in mitochondria that strongly affect oxidative phosphorylation (OXPHOS) capacity. Of note, to recycle oxidized cardiolipins and newly resynthesize them may be energetically challenging in an environment where energy production is already scarce. The interaction between oxidized cardiolipin and cytochrome c could be responsible for the substantial upregulation of the apoptotic pathways that is often detected in sarcopenic muscle. Indeed, while the cardiolipin content of mitochondria has been shown to decrease with aging, changes in different species of oxidized cardiolipins have not been studied in depth because of the lack of quantitative, reliable, and sensitive measurement methods. Because of its potential therapeutic implications, the study of cardiolipins is an active area of research.

      Anabolic resistance

      Discovery metabolomic studies that compared pairs of individuals with low and high muscle quality matched by age, sex, and body size found that plasma levels of branched‐chain amino acids (BCAAs) were higher in individuals with low compared with high muscle quality, operationalized as the ratio between muscle mass and muscle strength [50]. Interestingly, opposite to what had been found in blood, level of BCAAs in the muscle of participants with low muscle quality were higher than that in those with high muscle quality. While the reason behind these findings is not clear, these results are consistent with the notion that the administration of BCAAs, such as leucine, in the diet may prevent age‐related decline of muscle strength, decrease muscle fatigue, and alleviate muscle soreness, although there is some indication that this effect could be blunted in older persons [51, 52]. The scarcity of BCAAs within myofibers has important consequences. In myofibers, BCAAs have been shown to stimulate the Pi3K/Akt/mTOR cell signaling pathway; in particular, the mTORC1 controls protein synthesis by activating S6 kinase 1 (S6K1) and inhibiting 4E‐binding protein 1 (4EBP1) [53]. Low BCAAs lead to reduced protein synthesis and over time protein damage accumulation and lower muscle mass. Low BCAA availability also directly impacts mitochondria through at least two main mechanisms. Deficient mTORC1 activation and reduced SIRT1 biological activity, secondary to low BCAA availability in myofibers, contribute to a deficit in mitochondrial metabolism by underexpression of PGC1α, a master regulator of mitochondrial biogenesis. In addition, BCAAs undergo transamination by branched‐chain aminotransferases (BCATs) to form branched‐chain alpha‐ketoacids (BCKAs), and oxidative decarboxylation by the mitochondrial branched‐chain alpha‐ketoacid dehydrogenase (BCKDH) complex. This last step is highly modulated by factors that affect

Скачать книгу